The global escitalopram market is anticipated to grow at a significant CAGR of nearly 3.0% during the forecast period (2022-2028). The major factor expected to drive the market is the rising prevalence of major depressive disorder across the globe and the availability of low-cost generic versions of escitalopram drive the market growth. In addition, the […]
